Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Open-Labeled, Multicenter Phase II Study of Bortezomib for Maintenance Therapy in Patients with High Risk Diffuse Large B Cell Lymphoma (DLBCL): Borma Trial from Consortium for Improving Survival of Lymphoma (CISL)open access
- Authors
- Jo, Jae-Cheol; Lee, Ho Sup; Suh, Cheolwon; Kang, Hye Jin; Kim, Won Seog; Eom, HyeonSeok; Kim, Inho; Shin, Ho-Jin; Park, Yong; Lee, Won Sik; Do, Young Rok; Gyeong-Won, Lee; Oh, Sung Yong; Lim, Sung-Nam; Lee, Seong Yoon
- Issue Date
- 13-Nov-2019
- Publisher
- American Society of Hematology
- Citation
- Blood, v.134
- Indexed
- SCI
SCIE
SCOPUS
- Journal Title
- Blood
- Volume
- 134
- ISSN
- 0006-4971
1528-0020
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.